Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
- PMID: 19773352
- PMCID: PMC2759336
- DOI: 10.1093/brain/awp191
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
Erratum in
- Brain. 2012 Apr;135(Pt 4):1335
Abstract
Several molecular subtypes of sporadic Creutzfeldt-Jakob disease have been identified and electroencephalogram and cerebrospinal fluid biomarkers have been reported to support clinical diagnosis but with variable utility according to subtype. In recent years, a series of publications have demonstrated a potentially important role for magnetic resonance imaging in the pre-mortem diagnosis of sporadic Creutzfeldt-Jakob disease. Magnetic resonance imaging signal alterations correlate with distinct sporadic Creutzfeldt-Jakob disease molecular subtypes and thus might contribute to the earlier identification of the whole spectrum of sporadic Creutzfeldt-Jakob disease cases. This multi-centre international study aimed to provide a rationale for the amendment of the clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Patients with sporadic Creutzfeldt-Jakob disease and fluid attenuated inversion recovery or diffusion-weight imaging were recruited from 12 countries. Patients referred as 'suspected sporadic Creutzfeldt-Jakob disease' but with an alternative diagnosis after thorough follow up, were analysed as controls. All magnetic resonance imaging scans were assessed for signal changes according to a standard protocol encompassing seven cortical regions, basal ganglia, thalamus and cerebellum. Magnetic resonance imaging scans were evaluated in 436 sporadic Creutzfeldt-Jakob disease patients and 141 controls. The pattern of high signal intensity with the best sensitivity and specificity in the differential diagnosis of sporadic Creutzfeldt-Jakob disease was identified. The optimum diagnostic accuracy in the differential diagnosis of rapid progressive dementia was obtained when either at least two cortical regions (temporal, parietal or occipital) or both caudate nucleus and putamen displayed a high signal in fluid attenuated inversion recovery or diffusion-weight imaging magnetic resonance imaging. Based on our analyses, magnetic resonance imaging was positive in 83% of cases. In all definite cases, the amended criteria would cover the vast majority of suspected cases, being positive in 98%. Cerebral cortical signal increase and high signal in caudate nucleus and putamen on fluid attenuated inversion recovery or diffusion-weight imaging magnetic resonance imaging are useful in the diagnosis of sporadic Creutzfeldt-Jakob disease. We propose an amendment to the clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease to include findings from magnetic resonance imaging scans.
Figures
Similar articles
-
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.Neurology. 2009 Jun 9;72(23):1994-2001. doi: 10.1212/WNL.0b013e3181a96e5d. Neurology. 2009. PMID: 19506221
-
Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.Arch Neurol. 2006 Jun;63(6):876-80. doi: 10.1001/archneur.63.6.876. Arch Neurol. 2006. PMID: 16769870
-
Assessing the newly proposed MRI criteria for diagnosing sporadic Creutzfeldt-Jakob disease.Neuroradiology. 2024 Nov;66(11):1907-1915. doi: 10.1007/s00234-024-03440-w. Epub 2024 Aug 13. Neuroradiology. 2024. PMID: 39136713
-
Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.Neurology. 2005 Feb 22;64(4):643-8. doi: 10.1212/01.WNL.0000151847.57956.FA. Neurology. 2005. PMID: 15728285 Review.
-
Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.Folia Neuropathol. 2004;42 Suppl B:24-38. Folia Neuropathol. 2004. PMID: 16903140 Review.
Cited by
-
Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up.Sci Rep. 2021 May 25;11(1):10837. doi: 10.1038/s41598-021-90366-5. Sci Rep. 2021. PMID: 34035398 Free PMC article.
-
Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids.Acta Neuropathol Commun. 2020 Jul 25;8(1):117. doi: 10.1186/s40478-020-00990-x. Acta Neuropathol Commun. 2020. PMID: 32711575 Free PMC article. Review.
-
EEG-EMG polygraphic study of dystonia and myoclonus in a case of Creutzfeldt-Jakob disease.Epilepsy Behav Case Rep. 2015 Jun 20;4:30-2. doi: 10.1016/j.ebcr.2015.05.002. eCollection 2015. Epilepsy Behav Case Rep. 2015. PMID: 26150924 Free PMC article.
-
Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.Alzheimers Res Ther. 2021 Apr 21;13(1):86. doi: 10.1186/s13195-021-00815-6. Alzheimers Res Ther. 2021. PMID: 33883011 Free PMC article.
-
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease.Alzheimers Dement (Amst). 2024 Feb 13;16(1):e12548. doi: 10.1002/dad2.12548. eCollection 2024 Jan-Mar. Alzheimers Dement (Amst). 2024. PMID: 38352040 Free PMC article.
References
-
- Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology. 2004;63:436–42. - PubMed
-
- Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg. 2007;109:54–7. - PubMed
-
- Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006;129:2278–87. - PubMed
-
- Fujita K, Nakane S, Harada M, Izumi Y, Kaji R. Diffusion tensor imaging in patients with Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2008;79:1304–6. - PubMed